Professional
Added to YB: 2024-08-21
Pitch date: 2024-06-30
TEM [bullish]
Tempus AI, Inc.
+90.84%
current return
Author Info
No bio for this author
Company Info
Tempus AI, Inc. operates as a healthcare technology company. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology companies, researchers, and other third parties.
Market Cap
$12.5B
Pitch Price
$37.00
Price Target
N/A
Dividend
N/A
EV/EBITDA
-82.74
P/E
-59.11
EV/Sales
11.84
Sector
Life Sciences Tools and Services
Category
growth
Baron Health Care Fund New Position: Tempus AI, Inc
TEM: AI diagnostics co. w/ 2 units: Genomics (cancer treatment sequencing) & Data. 200PB dataset: 7.7M clinical records, 1M+ imaging, 910K+ matched clinical/molecular profiles, 970K+ sequenced samples. Works w/ 19/20 top pharma cos. Unique dataset w/ high barriers. Underpenetrated market, poised for rapid growth. 9-figure deals w/ 3 biopharma cos.
Read full article (1 min)